Rezultaty Open Research Data Pilot (2) Draft of Data Management Plan Description of datasets data sharing and archiving Updated version of Data Management Plan Websites, patent fillings, videos etc. (2) Project website and communication pack Project website and promotional tools for workshops and meetings Consortium secured intranet This tool will facilitate communication and establish the principles of work within the consortium Documents, reports (1) Communication and dissemination update This report will provide an update on the implementation and impact of the communication and dissemination activities Publikacje Peer reviewed articles (17) Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection Autorzy: Vanessa Monteil, Matheus Dyczynski, Volker M Lauschke, Hyesoo Kwon, Gerald Wirnsberger, Sonia Youhanna, Haibo Zhang, Arthur S Slutsky, Carmen Hurtado del Pozo, Moritz Horn, Nuria Montserrat, Josef M Penninger, Ali Mirazimi Opublikowane w: EMBO Molecular Medicine, Numer 13/1, 2021, Strona(/y) 13:e13426, ISSN 1757-4676 Wydawca: John Wiley & Sons Ltd. DOI: 10.15252/emmm.202013426 The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2 Autorzy: Omer Ziv, Jonathan Price, Lyudmila Shalamova, Tsveta Kamenova, Ian Goodfellow, Friedemann Weber, Eric A. Miska Opublikowane w: Molecular Cell, Numer 80/6, 2020, Strona(/y) 1067-1077.e5, ISSN 1097-2765 Wydawca: Cell Press DOI: 10.1016/j.molcel.2020.11.004 Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) is a host factor for RNA viruses including SARS-CoV-2 Autorzy: Stephanie Devignot, Tim Wai Sha, Thomas Burkard, Patrick Schmerer, Astrid Hagelkruys, Ali Mirazimi, Ulrich Elling, Josef M. Penninger, Friedemann Weber Opublikowane w: BioRxiv, 2022, ISSN 2692-8205 Wydawca: Cold Spring Harbor Laboratory, USA DOI: 10.1101/2022.02.17.480904 ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology Autorzy: Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F, Cronin SJ, Ohradanova-Repic A, Wirnsberger G, Agerer B, Endler L, Capraz T, Perthold JW, Cikes D, Koglgruber R, Hagelkruys A, Montserrat N, Mirazimi A, Boon L, Stockinger H, Bergthaler A, Oostenbrink C, Penninger JM, Knapp S. Opublikowane w: Elife, 2022, ISSN 2050-084X Wydawca: eLife Sciences Publications DOI: 10.7554/elife.74623 Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level. Autorzy: Zhu R, Canena D, Sikora M, Klausberger M, Seferovic H, Mehdipour AR, Hain L, Laurent E, Monteil V, Wirnsberger G, Wieneke R, Tampé R, Kienzl NF, Mach L, Mirazimi A, Oh YJ, Penninger JM, Hummer G, Hinterdorfer P. Opublikowane w: Nat Commun., 2022, Strona(/y) 2022 Dec 24;13(1):7926., ISSN 2041-1723 Wydawca: Nature Publishing Group DOI: 10.1038/s41467-022-35641-3 Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic Autorzy: Oudit GY, Wang K, Viveiros A, Kellner MJ, Penninger JM. Opublikowane w: Cell, 2023, Strona(/y) 2023 Mar 2;186(5):906-922., ISSN 1097-4172 Wydawca: Elsevier DOI: 10.1016/j.cell.2023.01.039 Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites Autorzy: Hoffmann D, Mereiter S, Jin Oh Y, Monteil V, Elder E, Zhu R, Canena D, Hain L, Laurent E, Grünwald-Gruber C, Klausberger M, Jonsson G, Kellner MJ, Novatchkova M, Ticevic M, Chabloz A, Wirnsberger G, Hagelkruys A, Altmann F, Mach L, Stadlmann J, Oostenbrink C, Mirazimi A, Hinterdorfer P, Penninger JM. Opublikowane w: EMBO Journal, 2021, ISSN 0261-4189 Wydawca: Nature Publishing Group DOI: 10.15252/embj.2021108375 Assessing kidney development and disease using kidney organoids and CRISPR engineering Autorzy: Safi W; Marco A; Moya D; Prado P; Garreta E; Montserrat N Opublikowane w: Frontiers In Cell And Developmental Biology, 2022, ISSN 2296-634X Wydawca: Frontiers Media Sa DOI: 10.3389/fcell.2022.948395 Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells Autorzy: Garreta E, Moya-Rull D, Stanifer ML, Monteil V, Prado P, Marco A, Tarantino C, Gallo M, Jonsson G, Hagelkruys A, Mirazimi A, Boulant S, Penninger JM, Montserrat N. Opublikowane w: Star Protocols, 2022, ISSN 2666-1667 Wydawca: Cell Press DOI: 10.1016/j.xpro.2022.101872 Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor Autorzy: Capraz T, Kienzl NF, Laurent E, Perthold JW, Föderl-Höbenreich E, Grünwald-Gruber C, Maresch D, Monteil V, Niederhöfer J, Wirnsberger G, Mirazimi A, Zatloukal K, Mach L, Penninger JM, Oostenbrink C, Stadlmann J. Opublikowane w: Elife, 2021, ISSN 2050-084X Wydawca: eLife Sciences Publications DOI: 10.7554/elife.73641 Human recombinant soluble ACE2 in severe COVID-19 Autorzy: Alexander Zoufaly, Marko Poglitsch, Judith H Aberle, Wolfgang Hoepler, Tamara Seitz, Marianna Traugott, Alexander Grieb, Erich Pawelka, Hermann Laferl, Christoph Wenisch, Stephanie Neuhold, Doris Haider, Karin Stiasny, Andreas Bergthaler, Elisabeth Puchhammer-Stoeckl, Ali Mirazimi, Nuria Montserrat, Haibo Zhang, Arthur S Slutsky, Josef M Penninger Opublikowane w: The Lancet Respiratory Medicine, Numer 8/11, 2020, Strona(/y) 1154-1158, ISSN 2213-2600 Wydawca: Elsevier Limited DOI: 10.1016/s2213-2600(20)30418-5 A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo. Autorzy: Chan JF, Oh YJ, Yuan S, Chu H, Yeung ML, Canena D, Chan CC, Poon VK, Chan CC, Zhang AJ, Cai JP, Ye ZW, Wen L, Yuen TT, Chik KK, Shuai H, Wang Y, Hou Y, Luo C, Chan WM, Qin Z, Sit KY, Au WK, Legendre M, Zhu R, Hain L, Seferovic H, Tampé R, To KK, Chan KH, Thomas DG, Klausberger M, Xu C, Moon JJ, Stadlmann J, Penninger JM, Oostenbrink C, Hinterdorfer P, Yuen KY, Markovitz DM. Opublikowane w: Cell Rep Med, 2022, Strona(/y) 2022 Oct 18;3(10):100774., ISSN 2666-3791 Wydawca: Cell Press DOI: 10.1016/j.xcrm.2022.100774 Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants Autorzy: Monteil V, Eaton B, Postnikova E, Murphy M, Braunsfeld B, Crozier I, Kricek F, Niederhöfer J, Schwarzböck A, Breid H, Devignot S, Klingström J, Thålin C, Kellner MJ, Christ W, Havervall S, Mereiter S, Knapp S, Sanchez Jimenez A, Bugajska-Schretter A, Dohnal A, Ruf C, Gugenberger R, Hagelkruys A, Montserrat N, Kozieradzki I, Hasan Ali O, Stadlmann J, Holbrook MR, Schmaljohn C, Oostenbrink C, Sh Opublikowane w: EMBO Mol Med., Numer 17574676, 2022, ISSN 1757-4676 Wydawca: John Wiley & Sons Ltd. DOI: 10.15252/emmm.202115230 Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer. Autorzy: Shoemaker RH, Panettieri RA Jr, Libutti SK, Hochster HS, Watts NR, Wingfield PT, Starkl P, Pimenov L, Gawish R, Hladik A, Knapp S, Boring D, White JM, Lawrence Q, Boone J, Marshall JD, Matthews RL, Cholewa BD, Richig JW, Chen BT, McCormick DL, Gugensberger R, Höller S, Penninger JM, Wirnsberger G. Opublikowane w: PLoS One, 2022, Strona(/y) 2022 Jul 11;17(7):e0271066. , ISSN 1932-6203 Wydawca: Public Library of Science DOI: 10.1371/journal.pone.0271066 Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response Autorzy: Lyudmila Shalamova, Ulrike Felgenhauer, Jochen Wilhelm, Andreas R Schaubmar, Kathrin Büttner, Andreas Schoen, Marek Widera, Sandra Ciesek, Friedemann Weber Opublikowane w: PNAS Nexus, 2022, ISSN 2752-6542 Wydawca: Oxford University Press DOI: 10.1093/pnasnexus/pgac067 A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells Autorzy: Garreta E, Prado P, Stanifer ML, Monteil V, Marco A, Ullate-Agote A, Moya-Rull D, Vilas-Zornoza A, Tarantino C, Romero JP, Jonsson G, Oria R, Leopoldi A, Hagelkruys A, Gallo M, González F, Domingo-Pedrol P, Gavaldà A, Del Pozo CH, Hasan Ali O, Ventura-Aguiar P, Campistol JM, Prosper F, Mirazimi A, Boulant S, Penninger JM, Montserrat N. Opublikowane w: Cell Metab., 2022, ISSN 1550-4131 Wydawca: Cell Press DOI: 10.1016/j.cmet.2022.04.009 Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19. Autorzy: Sinnberg T, Lichtensteiger C, Ali OH, Pop OT, Jochum AK, Risch L, Brugger SD, Velic A, Bomze D, Kohler P, Vernazza P, Albrich WC, Kahlert CR, Abdou MT, Wyss N, Hofmeister K, Niessner H, Zinner C, Gilardi M, Tzankov A, Röcken M, Dulovic A, Shambat SM, Ruetalo N, Buehler PK, Scheier TC, Jochum W, Kern L, Henz S, Schneider T, Kuster GM, Lampart M, Siegemund M, Bingisser R, Schindler M, Schneiderhan- Opublikowane w: Am J Respir Crit Care Med, 2023, Strona(/y) 2023 Jan 1;207(1):38-49., ISSN 1097-4172 Wydawca: the American Thoracic Society DOI: 10.1164/rccm.202201-0011oc Wyszukiwanie danych OpenAIRE... Podczas wyszukiwania danych OpenAIRE wystąpił błąd Brak wyników